CXCL9 and neoplasm: provided evidence that adenovirus vector expressing interleukin (IL)‐7 (DC‐AdIL‐7) reduced the tumor burden via the increase of IFN‐γ and IL‐12 as well as the antiangiogenic endogenous chemokines CXCL10 and CXCL9, and the decrease of immunosuppressive cytokines TGF‐β and VEGF 100.